This special edition of All Things Cancer features a powerful conversation with Dr. Rakesh Jain—pioneering scientist, educator, and longtime NFCR-supported researcher—on the eve of receiving the 2025 AACR Lifetime Achievement Award.

In this inspiring episode, Dr. Jain sits down with NFCR President and CEO Dr. Sujuan Ba to reflect on his decades of groundbreaking work, including his revolutionary concept of vascular normalization, which has reshaped how we treat cancer. Together, they discuss:

• How unconventional thinking led to new cancer therapies

• The impact of NFCR’s early seed funding on high-risk research

• The promise of affordable treatments like Losartan for brain tumors

• Why collaboration and bold science are essential to progress

“Without risk, science can’t move forward. NFCR understood that from the beginning.” – Dr. Rakesh Jain

Tune in to hear how Dr. Jain’s work is saving lives, shaping clinical trials, and making the future of cancer care more accessible—around the world.

🎧 Listen now and subscribe so you don’t miss future episodes.